Since the Gatwick meeting at the end of January we have been discussing the setting up of Special Interest Groups (SIGs) and finally Prof Daniel Steenstra has got this one off the ground. The first meeting at the end of October was recorded and transcribed Disruptive Innovation as applied to Health is a controversial theme and indeed a very recent article in the Harvard Business Review by the inventor of the concept, Clayton Christensen (here) discusses at length the misunderstandings that have arisen since he introduced the concept.
We are privileged to have in our SIG group, apart from Prof Daniel Steenstra, David Somekh and Matthijs Zwier, Prof John Ovretveit from Karolinska, Dr Peter Patel an expert in Primary Care Commissioning from Birmingham, Dr Alison Prendiville, Senior Researcher for the School of Graphic Design at the London College of Communication, Dr Alexander Peine, Assistant Professor of Science, Technology and Innovation Studies (STI-Studies) at Utrecht University and Dr Niels Boye, CEO at Klinisk Informatik in Region Midtjylland, Denmark.
The full notes of the meeting are here. A discussion point at this meeting was the current consultation on the paper on Disruptive Innovation in health produced by the Commission’s Expert Panel on Future investment in health (EXPH), which is here. We aim to formulate a response prior to the Dec.16th consultation deadline.